Severe endoscopic lesions are not associated with more infliximab fecal loss in acute severe ulcerative colitis

In ASUC, SEL were not associated with more loss of IFX in the stool or lower plasmatic levels. Early IFX pharmacokinetics in this setting does not seem related to endoscopic severity.